Fundz

Refoxy Pharmaceuticals raised €9.1M in a Seed extension round led by Boehringer Ingelheim Venture Fund to advance their research on therapeutics for age-related diseases.

PRIVATEDec 04, 2024

Amount Raised

€9.1 Million

Round Type

Seed

BerlinBiotechnologyHealth CareTherapeutics

Investors

Apollo Health VenturesHigh Tech GründerfondsNrw.VentureBoehringer Ingelheim Venture Fund

Description

Biotech Refoxy Pharmaceuticals has successfully raised €9.1 million in Seed-extension financing. The funding will support their development of novel therapeutic medicines, particularly targeting idiopathic pulmonary fibrosis (IPF).

Who else raised in Therapeutics and Biotechnology around the same time

Companies in the same sectors as Refoxy Pharmaceuticals that raised within 45 days of this round, from Fundz verified event records.

  • Phio Pharmaceuticals raised $153K (Seed) on January 17, 2025.
  • VisiRose raised $3M (Seed) on January 16, 2025.
  • Phio Pharmaceuticals raised $208K (Seed) on January 15, 2025.
  • Phio Pharmaceuticals raised $266K (Seed) on January 14, 2025.
  • First Ascent Biomedical raised $6M (Angel) on January 13, 2025.
  • Neumirna Therapeutics raised $20M (Series A) on January 13, 2025.

Who to call at Refoxy Pharmaceuticals, and when

A new round usually means Refoxy Pharmaceuticals is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Refoxy Pharmaceuticals raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Refoxy Pharmaceuticals, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Refoxy Pharmaceuticals. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Refoxy Pharmaceuticals

Location

Berlin, Berlin, Germany

About

Refoxy Pharma is a pre-clinical stage biotechnology company developing medicines for the treatment and prevention of aging and aging-associated diseases.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Refoxy Pharmaceuticals raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Refoxy Pharmaceuticals's next move

See what Strategic adds

Refoxy Pharmaceuticals raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.